Home Send email to LICA PHAMACEUTICALS Print Inform Colleague
 

The company owns promising internationally acknowledged intellectual proprietary rights on novel chalcone-based compounds as well as other classes of small molecules and their use as well as research data and know-how on the mechanism of action of these compounds. The company's compounds have shown unique effects against several microorganisms, such as bacteria and parasites, causing widespread diseases such as malaria, leishmaniasis, and hospital imnfections with resistant bacteria. Ownership of the compounds and their use by LICA Pharmaceuticals is protected by several wide-ranging patent applications and patents either pending or issued in many parts of the world.

The basis for the inventions described in the patent applications and patents issued which are owned by LICA Pharmaceuticals is a very large number of experiments carried out by the inventors during the past 15 years and described in the issued patents and filed patent applications.  The important findings described in these applications, and protected by approval of these patent applications, demonstrate the genuine and realistic potential for developing drugs for treating and/or preventing severe diseases killing millions of people each year. The broad and solid basis of the company’s issued patents and patent applications provides us the freedom to operate and prevents our competitors from entering this field.

 

   
COPYRIGHT LICA PHARMACEUTICALS 2001